Prosecution Insights
Last updated: April 19, 2026
Application No. 18/573,044

COSMETIC COMPOSITION FOR THE HAIR AND USE THEREOF FOR HAIR AND/OR SCALP CARE

Non-Final OA §103§112
Filed
Dec 21, 2023
Examiner
TIEN, LUCY MINYU
Art Unit
1612
Tech Center
1600 — Biotechnology & Organic Chemistry
Assignee
Pierre Fabre Dermo-Cosmetique
OA Round
1 (Non-Final)
62%
Grant Probability
Moderate
1-2
OA Rounds
3y 0m
To Grant
95%
With Interview

Examiner Intelligence

Grants 62% of resolved cases
62%
Career Allow Rate
45 granted / 72 resolved
+2.5% vs TC avg
Strong +33% interview lift
Without
With
+32.9%
Interview Lift
resolved cases with interview
Typical timeline
3y 0m
Avg Prosecution
54 currently pending
Career history
126
Total Applications
across all art units

Statute-Specific Performance

§101
0.6%
-39.4% vs TC avg
§103
46.8%
+6.8% vs TC avg
§102
6.4%
-33.6% vs TC avg
§112
25.8%
-14.2% vs TC avg
Black line = Tech Center average estimate • Based on career data from 72 resolved cases

Office Action

§103 §112
DETAILED ACTION Notice of Pre-AIA or AIA Status The present application, filed on or after March 16, 2013, is being examined under the first inventor to file provisions of the AIA . Claim Rejections - 35 USC § 112 The following is a quotation of 35 U.S.C. 112(b): (b) CONCLUSION.—The specification shall conclude with one or more claims particularly pointing out and distinctly claiming the subject matter which the inventor or a joint inventor regards as the invention. The following is a quotation of 35 U.S.C. 112 (pre-AIA ), second paragraph: The specification shall conclude with one or more claims particularly pointing out and distinctly claiming the subject matter which the applicant regards as his invention. Claim 26 is rejected under 35 U.S.C. 112(b) or 35 U.S.C. 112 (pre-AIA ), second paragraph, as being indefinite for failing to particularly point out and distinctly claim the subject matter which the inventor or a joint inventor (or for applications subject to pre-AIA 35 U.S.C. 112, the applicant), regards as the invention. Claim 26 recites wherein the hair cosmetic composition further contains glycerin as a moisturizing agent. The claim is indefinite because the scope of the claim is unclear. It is not clear whether glycerin is the at least one moisturizing agent of claim 25, or an additional moisturizing agent. To obviate this issue, it is suggested to removed “further” in claim 26. Claim Rejections - 35 USC § 103 The following is a quotation of 35 U.S.C. 103 which forms the basis for all obviousness rejections set forth in this Office action: A patent for a claimed invention may not be obtained, notwithstanding that the claimed invention is not identically disclosed as set forth in section 102, if the differences between the claimed invention and the prior art are such that the claimed invention as a whole would have been obvious before the effective filing date of the claimed invention to a person having ordinary skill in the art to which the claimed invention pertains. Patentability shall not be negated by the manner in which the invention was made. The factual inquiries for establishing a background for determining obviousness under 35 U.S.C. 103 are summarized as follows: 1. Determining the scope and contents of the prior art. 2. Ascertaining the differences between the prior art and the claims at issue. 3. Resolving the level of ordinary skill in the pertinent art. 4. Considering objective evidence present in the application indicating obviousness or nonobviousness. Claims 19-32 and 34-37 are rejected under 35 U.S.C. 103 as being unpatentable over Schweinsberg et al. (US 2012/0201774 A1, 08/09/2012) (hereinafter Schweinsberg). Schweinsberg discloses cosmetic products for keratin fibers containing, in a cosmetic carrier in the form of a dispersed system, at least one modified starch (abs); at least one polymeric thickening agents including sclerotium gum and hydroxypropyl starch phosphate ([0290]) in amounts of 0.5-20 wt. % ([0292]); and care-providing substances such as cationic surfactants, including amidoamine types ([0270]). Schweinsberg discloses a hair cosmetic comprising a mixture of: sclerotium gum (i.e. claimed microbial polysaccharide of claim 31) and hydroxypropyl starch phosphate (i.e. claimed modified starch of claim 32) ([0290]) and a cationic surfactant as a care-providing substance ([0270}) in a cosmetic carrier (abs). Schweinsberg does not disclose wherein the hair cosmetic must comprise silicones or quaternary ammoniums. Together these would provide a hair cosmetic composition as instantly claimed. The prior art is not anticipatory insofar as this combination must be selected from various lists/locations in the reference. It would have been obvious, however, to make the combination since all the claimed elements were known in the prior art and one skilled in the art could have combined the elements as claimed by known methods with no change in their respective functions, and the combination yielded nothing more than predictable results to one of ordinary skill in the art. See MPEP § 2143 (I)(A). Regarding claims 19 and 27 reciting various amounts of the at least one modified starch, the claimed amounts (i.e. 1-5% wt., or 2-4.5% wt., respectively) would have been obvious to one of ordinary skill in the art since they overlap with the ranges of the prior art (i.e. 0.5-20% wt.). In the case where the claimed ranges "overlap or lie inside ranges disclosed by the prior art" a prima facie case of obviousness exists. See MPEP § 2144.05(I). Regarding claim 20, Schweinsberg discloses wherein the carrier includes a water-containing cosmetic carrier (i.e. aqueous) ([0015]). Schweinsberg does not explicitly disclose an amount of water. However, it would have taken no more than the relative skill of one of ordinary skill in the art to have arrived at the claimed amount of water (i.e. at least 60% by weight) through routine experimentation based on the amount of carrier desired. Where the general conditions of a claim are disclosed in the prior art, it is not inventive to discover the optimum or workable ranges by routine experimentation. See MPEP § 2144.05(II)(A). Regarding claim 21, Schweinsberg does not wherein the hair cosmetic must comprise additional fatty substances. Regarding claim 22, Schweinsberg does not explicitly disclose a claimed dynamic viscosity range. However, since the cosmetic product of Schweinsberg comprises substantially the same active ingredients (i.e. sclerotium gum as a microbial polysaccharide; hydroxypropyl starch phosphate as a modified starch; and a cationic surfactant, in a cosmetic carrier) in about the same amounts, one of ordinary skill in the art would reasonably conclude the cosmetic product of Schweinsberg to reasonably possess the same properties as the claimed invention, such as a dynamic viscosity, measured at 22° C. by rotary viscometer at a shear rate of 17.7 s-1, of between 1,200 and 4,000 Pa·s. Regarding claim 23, Schweinsberg does not disclose wherein the hair cosmetic must comprise anionic or nonionic surfactants. Regarding claim 24, Schweinsberg further discloses wherein the cosmetic carrier contains active substances ([0015]). Regarding claims 25 and 26, Schweinsberg further discloses wherein the cosmetic carrier further comprises glycerol ([0171]). Regarding claims 28-29 reciting various amounts of the at least one microbial polysaccharide, the claimed amounts (i.e. 0.1-0.5% wt., or 2-4.5% wt., respectively) would have been obvious to one of ordinary skill in the art since they overlap with the ranges of the prior art (i.e. 0.5-20% wt.). In the case where the claimed ranges "overlap or lie inside ranges disclosed by the prior art" a prima facie case of obviousness exists. See MPEP § 2144.05(I). Regarding claim 30, Schweinsberg does not explicitly disclose an amount of cationic surfactant. However, since cationic surfactants are care-providing substances, it would have taken no more than the relative skill of one of ordinary skill in the art to have arrived at the claimed amount of cationic surfactant (i.e. 1-4% wt.) through routine experimentation based on the level of care desired. "[W]here the general conditions of a claim are disclosed in the prior art, it is not inventive to discover the optimum or workable ranges by routine experimentation." See MPEP § 2144.05(II)(A). Regarding claim 34, Schweinsberg does not disclose wherein the hair cosmetic must comprise silanes. Regarding claim 35, Schweinsberg further discloses an embodiment wherein the cosmetic product comprises an additional oil phase in an amount of 0.05 wt.% to 25 wt. % ([0214]). As such, the claimed amount (i.e. lower than or equal to 1% by weight) of fatty substances would have been obvious to one of ordinary skill in the art since they overlap with the ranges of the prior art (i.e. 0.05-25% wt.). In the case where the claimed ranges "overlap or lie inside ranges disclosed by the prior art" a prima facie case of obviousness exists. See MPEP § 2144.05(I). Regarding claims 36-37, Schweinsberg further discloses wherein the product is applied to hair after the hair strands were washed with a detergent solution (i.e. shampoo) ([0362]). Claim 33 is rejected under 35 U.S.C. 103 as being unpatentable over Schweinsberg et al. (US 2012/0201774 A1, 08/09/2012) (hereinafter Schweinsberg) in view of Rughani et al. (US 2018/0280267 A1, 10/04/2018) (hereinafter Rughani). The disclosure of Schweinsberg has been discussed in detail above, and differs from the instant claim insofar as not explicitly disclosing wherein the cationic surfactant of the amidoamine type comprises behenamidopropyl dimethylamine. However, Rughani discloses one or more hair treatment compositions comprising cationic surfactants ([0138]) including behenamidopropyldimethylamine ([0145]). Schweinsberg discloses a cosmetic product for treating hair comprising a cationic surfactant. Accordingly, it would have been obvious to one of ordinary skill in the art to have included behenamidopropyldimethylamine in the product of Schweinsberg, since it is a known and effective cationic surfactant suitable for hair treatment products as taught by Rughani. Citation of Pertinent Prior Art The prior art made of record and not relied upon is considered pertinent to applicant's disclosure. Sun et al. (US 2018/0344619 A1, 12/06/2018), directed to compositions comprising an organic compound B) and thickeners. Bendejacq et al. (US 2012/0021025 A1, 1/26/2016), directed to aqueous compositions as hair treatment comprising cationic surfactant and rheology modifiers. Conclusion Any inquiry concerning this communication or earlier communications from the examiner should be directed to LUCY TIEN whose telephone number is (571)272-8267. The examiner can normally be reached Monday - Thursday 8:30 AM - 6:30 PM EST. Examiner interviews are available via telephone, in-person, and video conferencing using a USPTO supplied web-based collaboration tool. To schedule an interview, applicant is encouraged to use the USPTO Automated Interview Request (AIR) at http://www.uspto.gov/interviewpractice. If attempts to reach the examiner by telephone are unsuccessful, the examiner’s supervisor, SAHANA KAUP can be reached at (571) 272-6897. The fax phone number for the organization where this application or proceeding is assigned is 571-273-8300. Information regarding the status of published or unpublished applications may be obtained from Patent Center. Unpublished application information in Patent Center is available to registered users. To file and manage patent submissions in Patent Center, visit: https://patentcenter.uspto.gov. Visit https://www.uspto.gov/patents/apply/patent-center for more information about Patent Center and https://www.uspto.gov/patents/docx for information about filing in DOCX format. For additional questions, contact the Electronic Business Center (EBC) at 866-217-9197 (toll-free). If you would like assistance from a USPTO Customer Service Representative, call 800-786-9199 (IN USA OR CANADA) or 571-272-1000. /LUCY M TIEN/Examiner, Art Unit 1612 /SAHANA S KAUP/Supervisory Primary Examiner, Art Unit 1612
Read full office action

Prosecution Timeline

Dec 21, 2023
Application Filed
Jan 12, 2026
Non-Final Rejection — §103, §112 (current)

Precedent Cases

Applications granted by this same examiner with similar technology

Patent 12558321
Pharmaceutical Formulation
2y 5m to grant Granted Feb 24, 2026
Patent 12521352
TASTE MASKING DRUG FORMULATIONS
2y 5m to grant Granted Jan 13, 2026
Patent 12521335
COSMETIC COMPOSITIONS CONTAINING VITAMIN C COMPOUNDS AND USES THEREOF
2y 5m to grant Granted Jan 13, 2026
Patent 12516062
AGRICULTURAL OR HORTICULTURAL INSECTICIDE OR ANIMAL ECTOPARASITE OR ENDOPARASITE CONTROL AGENT EACH COMPRISING AN IMIDAZOPYRIDAZINE COMPOUND HAVING A SUBSTITUTED CYCLOPROPANE-OXADIAZOLE GROUP OR A SALT THEREOF AS ACTIVE INGREDIENT, AND METHOD FOR USING THE INSECTICIDE OR THE CONTROL AGENT
2y 5m to grant Granted Jan 06, 2026
Patent 12496340
VACCINE ADJUVANTS BASED ON TLR RECEPTOR LIGANDS
2y 5m to grant Granted Dec 16, 2025
Study what changed to get past this examiner. Based on 5 most recent grants.

AI Strategy Recommendation

Get an AI-powered prosecution strategy using examiner precedents, rejection analysis, and claim mapping.
Powered by AI — typically takes 5-10 seconds

Prosecution Projections

1-2
Expected OA Rounds
62%
Grant Probability
95%
With Interview (+32.9%)
3y 0m
Median Time to Grant
Low
PTA Risk
Based on 72 resolved cases by this examiner. Grant probability derived from career allow rate.

Sign in with your work email

Enter your email to receive a magic link. No password needed.

Personal email addresses (Gmail, Yahoo, etc.) are not accepted.

Free tier: 3 strategy analyses per month